Pharmaceuticals, Biotechnology and Life Sciences
BRISBANE, CALIFORNIA, Dec. 30, 2022 (GLOBE NEWSWIRE) — GT Biopharma, Inc. (the “Company” or “GTB”) (NASDAQ: GTBP), a clinical stage…
The Phase 2 multicenter, open-label combination trial builds upon the promising results of monotherapeutic activity of ONC-392 seen in previous…
Cash runway now expected to extend into at least 2025 as a result of revised timeline of global Phase 3…
JERUSALEM, Dec. 30, 2022 (GLOBE NEWSWIRE) — via InvestorWire – BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV), a biotechnology company focused on developing,…
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH…
LONDON and NEW YORK, Dec. 30, 2022 (GLOBE NEWSWIRE) — OKYO Pharma Limited (LSE: OKYO, NASDAQ: OKYO), an ophthalmology-focused bio-pharmaceutical…
WINNIPEG, Manitoba, Dec. 29, 2022 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today…
The combined company will operate as Disc Medicine and will trade on the Nasdaq Global Market under the ticker symbol…
LONDON, Dec. 29, 2022 (GLOBE NEWSWIRE) — Tiziana Life Sciences Ltd (“Tiziana”, NASDAQ: TLSA), a biotechnology company enabling breakthrough CNS…
NEW YORK, Dec. 29, 2022 (GLOBE NEWSWIRE) — Following the formation of Mayflower Bioventures, a cell and gene therapy accelerator…